Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Insights Research Organization & Solutions (IROS) is a premier Contract Research Organization (CRO) based in Abu Dhabi, United Arab Emirates, dedicated to advancing clinical research in the Middle East and North Africa (MENA) region. Launched as the first UAE-headquartered private CRO, it provides end-to-end services for Phase I through Phase IV clinical trials, including site selection, regulatory submissions, and data management. IROS specializes in bridging the gap between global pharmaceutical standards and regional healthcare needs, focusing on diverse genomic data and real-world evidence. The organization is a key entity within M42, a global tech-enabled healthcare company formed by the merger of G42 Healthcare and Mubadala Health. By utilizing cutting-edge technology and local expertise, IROS supports the development of personalized medicine and innovative treatments across various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Insights Research Organization & Solutions.